Aethlon Medical
| Public | |
| Traded as | NASDAQ: AEMD |
| Genre | Biotechnology |
| Headquarters | San Diego, California, USA |
| Website | www.aethlonmedical.com |
Aethlon Medical Inc. is a public company based in San Diego, California that trades on the NASDAQ under the ticker symbol "AEMD."[1][2] Aethlon is said to develop medical devices to treat infectious disease and cancer by filtering harmful substances such as viruses from the blood.[3]
Hemopurifier
In development by Aethlon is the Hemopurifier, described as a single-use disposable cartridge for use with dialysis machines and other blood circulatory pumps. During October, 2014, the Hemopurifier was used as an adjunct therapy in the treatment of a patient who was suffering from Ebola. The patient subsequently recovered, although it was not clear which of several experimental therapies, if any, were responsible for his recovery.[4] The FDA subsequently approved the device for testing in up to 20 infected Ebola cases in the United States.[5]
References
- ↑ "AEMD:NASDAQ CM Stock Quote - Aethlon Medical Inc". Bloomberg.
- ↑ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=AEMD
- ↑ "Aethlon Medical Inc. News". The New York Times.
- ↑ Park, Alice (14 November 2014). "New Ebola Treatment Filters Virus Out of the Blood". Time. Retrieved 3 January 2015.
- ↑ "UPDATE 1-FDA allows testing of Aethlon device in Ebola patients". Reuters. 2 January 2015. Retrieved 2 January 2015.